Knowthestock.com
ANIP - ANI Pharmaceuticals Inc

Sell

Revenue is Negative
WeakStrong
WeakStrong

21%

based on last 5 year data.
Income Statement is WEAK
Revenue is Negative
Operating Income Growth is -88.73%
Net Income is Negative
Earnings Per Share (EPS) is Negative
Net Margin not available
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 2.66
Debt Ratio is 0.66
Current Debt to Net Income Ratio is 0.73
Total Debt to Total Assets Ratio is 0.24
Cash Flow is WEAK
Cash from Operations Growth is -30.28%
Capital Expenditure not available
Net Increase in Cash is Negative
Long Term Score Trend is NEUTRAL
Investment Risk is High
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
ANI Pharmaceuticals Inc (ANIP) - http://www.anipharmaceuticals.com/
ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two pharmaceutical manufacturing facilities located in baudette, minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize cortrophin gel and cortrophin-zinc.
Exchange - NASDAQ
Industry - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector - Professional, Scientific, and Technical Services
CEO - Patrick Walsh
Employees - 280
    Close

    Login/Register

    Home


Cookie Policy
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2025 and future.